Pathogenesis and Biochemical Basis
The development of renal pathology in diabetes mellitus is rooted in generalized diabetic microangiopathy. This process is driven by two fundamental mechanisms: metabolic defects and hemodynamic shifts.
Metabolic disorders are directly linked to chronic hyperglycemia and insulin deficiency. Non-enzymatic protein glycosylation plays a pivotal role. This process leads to the excessive accumulation of advanced glycation end products (AGEs), triggering a cascade of structural changes known as glomerulopathy. At the biochemical level, an imbalance is observed: the synthesis of type IV collagen and fibronectin is sharply upregulated, whereas the production of proteoglycans (specifically, heparan sulfate) is critically reduced. The net result of this metabolic defect is marked thickening of the glomerular basement membrane (GBM) and a pathological expansion of the mesangial matrix volume.
Hemodynamic alterations act as the second major factor hypothesized to drive glomerulosclerosis. These changes are particularly prominent in Type 1 diabetes mellitus. Such patients exhibit an increased glomerular filtration rate (GFR), accompanied by elevated intracapillary pressure and an expanded effective filtration surface area. Persistent hemodynamic overload induces compensatory glomerular hypertrophy, which eventually becomes exhausted and transforms into irreversible glomerulosclerosis in 40% of patients.
Basement Membrane and Diffuse Sclerosis
The morphological picture of renal glomerular injury consists of three main components. The first and earliest sign is thickening of the capillary basement membrane. This is a universal manifestation of diabetic microangiopathy, occurring in virtually all patients with diabetes mellitus. Importantly, basement membrane thickening in isolation is not correlated with the onset of proteinuria. Definitive identification of true thickening requires electron microscopy. Concurrently, the basement membranes of the renal tubules undergo similar changes.
The second component is diffuse diabetic glomerulosclerosis. This is characterized by diffuse global thickening of the mesangial matrix, accompanied by moderate proliferation of mesangial cells. This process always develops against the background of preexisting widespread GBM thickening. The pathological progression follows a clear sequence:
- Changes originate in the vascular stalk of the renal corpuscle, where arteriolar hyalinosis develops.
- As the disease progresses, the mesangium expands, leading to a characteristic 'imprisonment' (encasement) of mesangial cells by the excess matrix.
- Gradually, sclerotic masses occupy the entire volume of the glomerulus, ultimately resulting in severe obliterating diabetic glomerulosclerosis.
Nodular Glomerulosclerosis
The third morphological variant is nodular glomerulosclerosis, also known in clinical practice by the synonyms intercapillary glomerulosclerosis or Kimmelstiel-Wilson disease (Kimmelstiel P., Wilson C.). This form develops in 15–30% of patients with diabetes mellitus and is clinically always accompanied by pronounced renal failure.
Macroscopically and under light microscopy, affected glomeruli acquire a characteristic oval or regular spherical shape. Due to the accumulation of dense hyaline masses at the periphery, they take on a specific laminated appearance. These pathological sclerotic nodules are localized strictly in the center of the mesangial areas of individual capillary lobules and are surrounded peripherally by preserved capillary loops.
The process is focal in nature: not all glomeruli are involved. In those renal corpuscles or individual lobules where nodules are absent, histology frequently reveals features of diffuse glomerulosclerosis. Histochemical staining demonstrates that the sclerotic nodules are PAS-positive, turning a saturated red-crimson color. Their biochemical composition reliably includes lipids and fibrin threads.